Home > Publications > Medical Specialty > Internal Medicine > Medical Oncology > Lung Cancer > Lung Cancer Research Review, Issue 81
Lung Cancer Research Review, Issue 81

Lung Cancer Research Review, Issue 81

In this issue:

Mutagenic forces shaping the lung cancer genomes in never-smokers
Molecular determinants of sotorasib efficacy in KRAS G12C-mutated NSCLC
D3S-001 in KRAS G12C-mutated advanced solid tumours
Adagrasib vs. docetaxel in KRAS G12C-mutated NSCLC
Post-RT durvalumab in unresectable, chemotherapy-ineligible stage III NSCLC
Stereotactic radiosurgery in SCLC with 1–10 brain metastases
Selecting limited-stage SCLC patients for prophylactic cranial RT
Second primary cancers in lung cancer survivors by treatment type
Obrixtamig for DLL3+ SCLC or neuroendocrine carcinomas
Time toxicity of systemic anticancer therapies for metastatic lung cancer

You need to be logged in to access this content.

Dr-Alexander-Davis

Expert contributor

Dr Alexander Davis

Dr Alexander Davis is a Medical Oncologist at Royal North Shore Hospital, North Shore Private Hospital and Genesis Care North Shore. He is currently undertaking a PhD in KRAS mutant lung cancers at the University of Sydney.

Latest Publications and Videos

Stay up to date with our latest clinical information.

Explore Research Review Publications and Videos

Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry. 

Find Reviews in Your Clinical Area
Please select your country of practice.

It looks like you are closest to our New Zealand site.

Terms and Conditions

Website terms of use 

By using our website, you agree to follow these terms and conditions. 

 

Privacy policy 

We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms. 

 

Copyright and use of website content 

The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use. 

You cannot:  copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission. 

 

Links to third-party websites 

The Research Review website may link to third-party websites for your convenience. However: 

We do not endorse or approve their products, services, or actions. 

We are not responsible for their content or how they operate. 

There is no formal partnership between us and third parties unless we clearly state otherwise. 

 

Disclaimer and limitation of liability 

We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date. 

To the fullest extent allowed by law, we are not responsible for: 

Any loss, damage, or costs you may suffer from using (or being unable to use) our website. 

Any decisions you make based on the information provided. 

Any business losses, such as lost profits, lost data, or business interruptions. 

 

Governing law 

These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.